TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
PharmaFocus AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,607
|
1,395
|
1,421 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
414
|
254
|
339 |
EBITDA |
388
|
307
|
396 |
Total assets |
2,389
|
2,212
|
2,302 |
Current assets |
2,389
|
2,212
|
2,233 |
Current liabilities |
241
|
284
|
273 |
Equity capital |
1,984
|
1,779
|
1,859 |
- share capital |
101
|
95
|
98 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
83.0%
|
80.4%
|
80.8% |
Turnover per employee |
1,607
|
1,395
|
1,421 |
Profit as a percentage of turnover |
25.8%
|
18.2%
|
23.9% |
Return on assets (ROA) |
17.4%
|
11.5%
|
14.7% |
Current ratio |
991.3%
|
778.9%
|
817.9% |
Return on equity (ROE) |
20.9%
|
14.3%
|
18.2% |
Change turnover |
112
|
17
|
25 |
Change turnover % |
8%
|
1%
|
2% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.